A PHASE 1B/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-04449913, AN ORAL HEDGEHOG INHIBITOR, IN COMBINATION WITH INTENSIVE CHEMOTHERAPY, LOW DOSE ARA-C OR DECITABINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA OR HIGH-RISK MYELODYSPLASTIC SYNDROME
收藏DataCite Commons2026-02-09 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012743/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a study to evaluate PF-04449913 (an inhibitor of the Hedgehog pathway) in Acute Myeloid Leukemia and high-risk Myelodysplastic Syndrome in combination with standard agents used to treat these diseases.
提供机构：
Vivli
创建时间：
2026-02-09
